Trainee Pearls podcast

#18 Jurjen Versluis: Transplant for high-risk MDS

2023-10-29
0:00
20:34
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder

Allogeneic hematopoietic cell transplantation (HCT) in patients with myelodysplastic syndrome (MDS) improves overall survival. The authors evaluated the impact of MDS genetics on the benefit of HCT in a biological assignment (donor v no donor) study. https://pubmed.ncbi.nlm.nih.gov/37607457/ ALSO AS VIDEO ON https://youtu.be/JbHS_-2sJQc CONNECT WITH US https://twitter.com/TheEBMT_Trainee https://www.ebmt.org/trainee-committee https://twitter.com/CarmeloGurnari


Fler avsnitt från "Trainee Pearls"